Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor κB signaling

Cancer Research

Volumn 66, Issue 10, 2006, Pages 5209-5215

  Ren, Qing ^a   Kari, Csaba ^a   Quadros, Marlene R D ^a   Burd, Randy ^a   McCue, Peter ^a   Dicker, Adam P ^a   Rodeck, Ulrich ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; KERATINOCYTE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RNA INTERFERENCE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR MATRIX; HUMANS; KERATINOCYTES; MICE; MICE, NUDE; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744928116     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-4158     Document Type: Article

References (32)

1. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immun 2000;18:621-63.
2. Luque I, Gelinas C. Rel/NF-κ and IκB factors in oncogenesis. Semin Cancer Biol 1997;8:103-11.
3. Aggarwal BB. Nuclear factor-κB: the enemy within. Cancer Cell 2004;6:203-8.
4. Duffey DC, Chen Z, Dong G, et al. Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 1999;59:3468-74.
5. Loercher A, Lee TL, Ricker JL, et al. Nuclear factor-κB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 2004;64:6511-23.
6. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-κB signaling. Int J Cancer 2004;111:679-92.
7. Dajee M, Lazarov M, Zhang JY, et al. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003;421:639-43.
8. van Hogerlinden M, Rozell BL, Ahrlund-Richter L, Toftgard R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling. Cancer Res 1999;59:3299-303.
9. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988;106:761-71.
10. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA. Nuclear factor κB subunits induce epithelial cell growth arrest. Cancer Res 2000;60:4085-92.
11. Seitz CS, Freiberg RA, Hinata K, Khavari PA. NF-κB determines localization and features of cell death in epidermis. J Clin Invest 2000;105:253-60.
12. Jost M, Huggett TM, Kari C, Boise LH, Rodeck U. Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway. J Biol Chem 2001;276:6320-6.
13. Jost M, Huggett TM, Kari C, Rodeck U. Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway. Mol Biol Cell 2001;12:1519-27.
14. Jost M, Kari C, Rodeck U. An episomal vector for stable tetracycline-regulated gene expression. Nucleic Acids Res 1997;25:3131-4.
15. Stoker M, O'Neill C, Berryman S, Waxman V. Anchorage and growth regulation in normal and virus-transformed cells. Int J Cancer 1968;3:683-93.
16. Weaver VM, Lelievre S, Lakins JN, et al. β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002;2:205-16.
17. Zahir N, Lakins JN, Russell A, et al. Autocrine laminin-5 ligates á6â4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 2003;163:1397-407.
18. Wang CY, Mayo MW, Baldwin AS, Jr. TNF-α and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κβ. Science 1996;274:784-7.
19. Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 1990;50:2840-7.
20. Moore RJ, Owens DM, Stamp G, et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 1999;5:828-31.
21. Seitz CS, Lin Q, Deng H, Khavari PA. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc Natl Acad Sci U S A 1998;95:2307-12.
22. Perkins ND. NF-κB: tumor promoter or suppressor? Trends Cell Biol 2004;14:64-9.
23. Kallassy M, Martel N, Damour O, Yamasaki H, Nakazawa H. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Mol Carcinogenesis 1998;21:26-36.
24. Boukamp P, Peter W, Pascheberg U, et al. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss. Oncogene 1995;11:961-9.
25. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Apoptosis in proliferating, senescent, and immortalized keratinocytes. J Biol Chem 1999;274:23358-67.
26. Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Abnormal NF-κB signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes. J Dermatol Sci 2001;26:67-78.
27. Harvat BL, Jetten AM. Decreased growth inhibitory responses of squamous carcinoma cells to interferon-γ involve failure to recruit cki proteins into cdk2 complexes. J Invest Dermatol 2001;117:1274-81.
28. Facchinetti MM, De Siervi A, Toskos D, Senderowicz AM. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(wafl/cipl) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway. Cancer Res 2004;64:3629-37.
29. Basile JR, Eichten A, Zacny V, Munger K. 4 NF-κB-mediated induction of p21(Cipl/Wafl) by tumor necrosis factor α induces growth arrest and cytoprotection in normal human keratinocytes. Mol Cancer Res 2003;1:262-70.
30. Rocha S, Garrett MD, Campbell KJ, Schumm K, Perkins ND. Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J 2005;24:1157-69.
31. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6.
32. Greten FR, Eckmann L, Greten TF, et al. Ikkβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-96.